In 2017, the total prevalent cases of Sjogren’s Syndrome in 7MM were 3,179,223. The prevalent cases in Spain was found to be 197,008 in 2017.
The market size of Sjogren’s Syndrome in 7MM in 2017 was USD 1,699.8 Million, which is expected to increase further during the forecast period 2017-2030.
The key companies involved in developing therapies for Sjogren’s Syndrome include Novartis, MorphoSys, Resolve Therapeutics, GlaxoSmithKline, VIELABIO, RemeGen, Bristol Myers Squibb and many others.
For more details visit: https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size